Artemis

What artemis MCP server does

The artemis MCP server exposes figures from a pharmacy, or officine, to an AI assistant through the Model Context Protocol. The available description identifies three data areas: sales, stock, and margins. This makes the server relevant to assistants that need to answer questions about pharmacy activity using operational data.

Access is explicitly read-only. An agent can use the connected information for inspection and analysis, but the supplied material does not indicate that it can update stock, change sales records, alter margins, or perform other write operations. The source material also does not describe additional business systems or external services connected to the server.

Tools and capabilities

The documented scope is limited but clear:

• Read pharmacy sales figures.
• Read pharmacy stock information.
• Read pharmacy margin data.
• Make those figures available in an AI assistant.
• Keep access read-only.

No individual MCP tool names, parameters, response formats, filtering options, reporting functions, or supported queries are provided. Developers should therefore treat the three named data categories as the confirmed capability boundary rather than assuming broader pharmacy-management features.

Limitations and notes

The artemis MCP server is suitable for read-oriented use cases only, based on the available description. It should not be selected for workflows that require changing inventory, recording sales, editing financial data, or triggering pharmacy operations.

The supplied material does not specify installation steps, environment variables, authentication, transport type, client compatibility, licensing, data refresh behavior, permissions, or deployment requirements. It also does not explain whether the server exposes aggregate reports, individual records, historical ranges, or custom queries. Those details should be confirmed with the provider before implementation.

The artemis MCP server may fit an assistant that needs to inspect sales, stock, or margin figures during a conversation. It is not possible from the available information to assess data granularity, performance, security controls, regional compliance, or how access to pharmacy data is provisioned. Keep those questions open during technical review rather than inferring support from the product description.